Elision International Inc. ELIS 深 滬
等待開盤 10-16 09:30:00 美东时间
23.2791
-0.416
-1.76%
華盛通- 最 高23.5988
- 今 開23.5988
- 成交量 718股
- 最 低 23.241
- 昨 收 23.695
- 總市值 290.99万
- 52周最高 31.1325
- 市盈率 靜 --
- 換手率 0.57%
- 52周最低 22.287
- 委 比 0.00%
- 總股本 12.50万
- 歷史最高 31.1325
- 量 比 0.32
- 振 幅 1.51%
- 歷史最低 22.287
- 每 手 1
- 風險率 1.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Healthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs
As the largest publicly traded U.S. healthcare enterprise, Eli Lilly & Co. ...
10-13 22:10
Immuron Advances FDA Filings And Preps 2025 Launch Of New IBS Treatment ProIBS, Eyes October Results For Travelan US Military Trial
Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to provide shareholders with a brief update on progress with a number of projects.SalesAs
10-02 18:08
加速生命科学大模型落地，腾讯构建了一个新的AI生态
众多投身生命科学的互联网公司中，腾讯或是最先破局的那一个。 2025年的腾讯全球数字生态大会中，腾讯健康总裁吴文达对腾讯的生命科学解决方案进行了一次全方位的拆解...
09-22 08:04
泰格医药子公司方达控股5月双捷报：苏州与上海实验室均以“零缺陷”通过FDA核查
2025年5月，方达控股旗下苏州生物分析实验室和上海生物分析实验室相继接受了美国食品药品监督管理局（FDA）的现场核查，均以“零缺陷”顺利通过，充分展现了方达控...
05-22 09:13
AbbVie Cancer Drug Approval Fails to Lift ABBV Stock
AbbVie stock fell alongside an analyst downgrade despite the company receiving ...
05-15 20:24
FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases
FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes $335 million upfront.
05-15 03:25
What's Going On With Revvity Stock Today?
Revvity's stock rose after FDA approval of its Auto-Pure 2400 platform integrated with the T-SPOT.TB test, improving latent TB detection efficiency in labs.
04-03 01:09
Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany
MINNEAPOLIS, March 26, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will open a new Customer Experience Centre in Düsseldorf, Germany to serve customers acro...
03-26 19:00
